Risk Of Hospitalisation
- All
- News
- Videos
-
On Hottest Days, Hospitalisation Risk Doubled For Sugar, BP Patients: Study
On the hottest days, risk of hospitalisation for people with metabolic disorders such as those of sugar and blood pressure, and obesity, almost doubled as compared to days recording comfortable temperatures, a new study has found.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Reduced Hospitalisation Risk For Omicron Patients: US Study
A preliminary US study of nearly 70,000 Covid positive people showed a substantially reduced risk of hospitalisation and death from Omicron even after controlling for growing population immunity levels.
-
Omicron Hospitalisation Rate Up To 70 Per Cent Lower: UK Agency
The risk of hospitalisation is up to 70 percent lower among people infected with the Omicron variant compared with previously dominant Delta, a UK government agency said Thursday.
-
Omicron Hospitalisation Risk Far Below Delta's In Early Studies
The Omicron variant of Covid-19 may be less likely to land patients in the hospital than the Delta strain, according to a trio of studies of preliminary data.
-
Omicron Hospitalisation Risk 40-45% Lower Than Delta: Study
The risk of needing to stay in hospital for patients with the Omicron variant of COVID-19 is 40% to 45% lower than for patients with the Delta variant, according to research by London's Imperial College published on Wednesday.
-
Omicron Cases Soar In South Africa But Symptoms "Far Milder": 10 Facts
Omicron has affected at least 57 countries so far and hospitalisations are likely to soar, the WHO said on Wednesday. "Emerging data from South Africa suggests increased risk of reinfection," WHO chief Tedros Adhanom Ghebreyesus said.
-
Antidepressant Fluvoxamine May Reduce Covid Hospitalisation Risk: Study
Treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study showed Thursday.
-
Blood Thinners Reduce Covid Deaths By 50%, Hospitalisation By 43%: US Study
Covid patients who use blood thinners may have a nearly 50% reduced risk of death and a 43% lower risk of hospitalisation, according to a study published in Lancet's EClinicalMedicine journal.
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Delta Variant Doubles Hospitalisation Risk In Comparison To Alpha: Study
The Delta variant of the virus that causes Covid-19 doubles the risk of hospitalisation compared to the Alpha variant it has supplanted as the dominant strain worldwide, researchers reported Saturday in The Lancet.
-
Vitamin K May Help Promote Heart Health - Expert Reveals; 5 Vitamin K-Rich Foods You Must Eat
People having more vitamin K1 were 21 percent less likely to be "hospitalised with cardiovascular disease related to atherosclerosis". And people having more vitamin K2 had 14 percent lower risk of being hospitalised.
-
UK Warns Of Increased Risk Of Covid Reinfection With Delta Variant
In UK, 3,692 people have been hospitalised with the Delta variant, of whom 2,152 (58.3 per cent) were unvaccinated and 843 (22.8 per cent) were fully vaccinated.
-
If Vaccinated, Hospitalisation Risk Falls 80%, Oxygen Need By 8%: Study
Studies show the risk of hospitalisation due to COIVID-19 falls by 70-80 per cent if a person is vaccinated, the government said today. After vaccination, the chances of a Covid patient needing medical oxygen also reduce by 8 per cent.
-
Delta Variant Doubles Risk Of COVID-19 Hospitalisation: Scottish Study
The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant variant in Britain, but two doses of vaccine still provide strong protection, a Scottish study found on Monday.
-
On Hottest Days, Hospitalisation Risk Doubled For Sugar, BP Patients: Study
On the hottest days, risk of hospitalisation for people with metabolic disorders such as those of sugar and blood pressure, and obesity, almost doubled as compared to days recording comfortable temperatures, a new study has found.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Reduced Hospitalisation Risk For Omicron Patients: US Study
A preliminary US study of nearly 70,000 Covid positive people showed a substantially reduced risk of hospitalisation and death from Omicron even after controlling for growing population immunity levels.
-
Omicron Hospitalisation Rate Up To 70 Per Cent Lower: UK Agency
The risk of hospitalisation is up to 70 percent lower among people infected with the Omicron variant compared with previously dominant Delta, a UK government agency said Thursday.
-
Omicron Hospitalisation Risk Far Below Delta's In Early Studies
The Omicron variant of Covid-19 may be less likely to land patients in the hospital than the Delta strain, according to a trio of studies of preliminary data.
-
Omicron Hospitalisation Risk 40-45% Lower Than Delta: Study
The risk of needing to stay in hospital for patients with the Omicron variant of COVID-19 is 40% to 45% lower than for patients with the Delta variant, according to research by London's Imperial College published on Wednesday.
-
Omicron Cases Soar In South Africa But Symptoms "Far Milder": 10 Facts
Omicron has affected at least 57 countries so far and hospitalisations are likely to soar, the WHO said on Wednesday. "Emerging data from South Africa suggests increased risk of reinfection," WHO chief Tedros Adhanom Ghebreyesus said.
-
Antidepressant Fluvoxamine May Reduce Covid Hospitalisation Risk: Study
Treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study showed Thursday.
-
Blood Thinners Reduce Covid Deaths By 50%, Hospitalisation By 43%: US Study
Covid patients who use blood thinners may have a nearly 50% reduced risk of death and a 43% lower risk of hospitalisation, according to a study published in Lancet's EClinicalMedicine journal.
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Delta Variant Doubles Hospitalisation Risk In Comparison To Alpha: Study
The Delta variant of the virus that causes Covid-19 doubles the risk of hospitalisation compared to the Alpha variant it has supplanted as the dominant strain worldwide, researchers reported Saturday in The Lancet.
-
Vitamin K May Help Promote Heart Health - Expert Reveals; 5 Vitamin K-Rich Foods You Must Eat
People having more vitamin K1 were 21 percent less likely to be "hospitalised with cardiovascular disease related to atherosclerosis". And people having more vitamin K2 had 14 percent lower risk of being hospitalised.
-
UK Warns Of Increased Risk Of Covid Reinfection With Delta Variant
In UK, 3,692 people have been hospitalised with the Delta variant, of whom 2,152 (58.3 per cent) were unvaccinated and 843 (22.8 per cent) were fully vaccinated.
-
If Vaccinated, Hospitalisation Risk Falls 80%, Oxygen Need By 8%: Study
Studies show the risk of hospitalisation due to COIVID-19 falls by 70-80 per cent if a person is vaccinated, the government said today. After vaccination, the chances of a Covid patient needing medical oxygen also reduce by 8 per cent.
-
Delta Variant Doubles Risk Of COVID-19 Hospitalisation: Scottish Study
The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant variant in Britain, but two doses of vaccine still provide strong protection, a Scottish study found on Monday.
